GERON CORP·4

Sep 21, 8:32 PM ET

SCARLETT JOHN A 4

4 · GERON CORP · Filed Sep 21, 2023

Insider Transaction Report

Form 4
Period: 2023-08-15
SCARLETT JOHN A
DirectorChief Executive Officer
Transactions
  • Award

    Employee Stock Option (Right to buy)

    2023-08-15+500,000500,000 total
    Exercise: $1.72From: 2023-08-15Exp: 2028-11-06Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES